Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 3 | 2024 | 1092 | 0.790 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2025 | 760 | 0.610 |
Why?
|
| Health Status Disparities | 1 | 2019 | 719 | 0.380 |
Why?
|
| Receptors, Steroid | 2 | 2025 | 38 | 0.350 |
Why?
|
| Breast Neoplasms | 2 | 2019 | 1723 | 0.330 |
Why?
|
| Immunity, Innate | 2 | 2024 | 171 | 0.330 |
Why?
|
| Chalcone | 1 | 2010 | 5 | 0.330 |
Why?
|
| Chalcones | 1 | 2010 | 17 | 0.330 |
Why?
|
| Neurites | 1 | 2010 | 40 | 0.330 |
Why?
|
| Liver | 2 | 2024 | 511 | 0.250 |
Why?
|
| Inflammation | 2 | 2024 | 758 | 0.240 |
Why?
|
| Xenobiotics | 1 | 2025 | 16 | 0.240 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2025 | 92 | 0.220 |
Why?
|
| Cell Proliferation | 1 | 2010 | 1455 | 0.210 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2025 | 131 | 0.210 |
Why?
|
| Heme Oxygenase-1 | 1 | 2024 | 52 | 0.210 |
Why?
|
| Basement Membrane | 1 | 2019 | 26 | 0.150 |
Why?
|
| Cell Adhesion Molecules | 1 | 2019 | 83 | 0.150 |
Why?
|
| Silver | 1 | 2019 | 61 | 0.140 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2019 | 97 | 0.140 |
Why?
|
| Genetic Variation | 2 | 2019 | 430 | 0.140 |
Why?
|
| Gene Expression Regulation | 2 | 2024 | 1070 | 0.140 |
Why?
|
| Oxidative Stress | 1 | 2024 | 1003 | 0.130 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 131 | 0.130 |
Why?
|
| Male | 6 | 2025 | 23409 | 0.130 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 277 | 0.120 |
Why?
|
| Metal Nanoparticles | 1 | 2019 | 230 | 0.120 |
Why?
|
| Obesity | 1 | 2024 | 1151 | 0.110 |
Why?
|
| Hepatocytes | 1 | 2015 | 80 | 0.110 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 1019 | 0.110 |
Why?
|
| Cathepsins | 2 | 2004 | 9 | 0.100 |
Why?
|
| Ethanol | 1 | 2015 | 224 | 0.100 |
Why?
|
| Humans | 8 | 2024 | 43102 | 0.090 |
Why?
|
| Chlorofluorocarbons, Methane | 1 | 2010 | 3 | 0.080 |
Why?
|
| Butadienes | 1 | 2010 | 29 | 0.080 |
Why?
|
| Culture Media, Serum-Free | 1 | 2010 | 44 | 0.080 |
Why?
|
| PC12 Cells | 1 | 2010 | 93 | 0.080 |
Why?
|
| Cytochrome P-450 CYP2E1 | 2 | 2024 | 24 | 0.080 |
Why?
|
| Nitriles | 1 | 2010 | 81 | 0.080 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2010 | 127 | 0.080 |
Why?
|
| Flavonoids | 1 | 2010 | 100 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 159 | 0.070 |
Why?
|
| Animals | 6 | 2025 | 16992 | 0.070 |
Why?
|
| United States | 1 | 2019 | 5205 | 0.070 |
Why?
|
| Mice | 4 | 2025 | 6644 | 0.070 |
Why?
|
| Models, Biological | 1 | 2010 | 712 | 0.060 |
Why?
|
| Cell Line | 1 | 2010 | 1410 | 0.060 |
Why?
|
| Cysteine Endopeptidases | 2 | 2004 | 64 | 0.060 |
Why?
|
| Lysosomes | 2 | 2004 | 86 | 0.060 |
Why?
|
| Apoptosis | 2 | 2012 | 1568 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2025 | 1869 | 0.060 |
Why?
|
| Enzyme Precursors | 2 | 2004 | 12 | 0.060 |
Why?
|
| Female | 3 | 2024 | 24698 | 0.060 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2024 | 18 | 0.050 |
Why?
|
| Adipose Tissue, White | 1 | 2024 | 18 | 0.050 |
Why?
|
| PPAR gamma | 1 | 2024 | 55 | 0.050 |
Why?
|
| I-kappa B Proteins | 1 | 2003 | 36 | 0.050 |
Why?
|
| Camptothecin | 1 | 2003 | 21 | 0.050 |
Why?
|
| Rats | 1 | 2010 | 3735 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2025 | 1035 | 0.050 |
Why?
|
| Glioma | 1 | 2003 | 96 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 2676 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2004 | 536 | 0.040 |
Why?
|
| Proteins | 1 | 2024 | 382 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2002 | 281 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2003 | 358 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2024 | 561 | 0.040 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2015 | 10 | 0.030 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2015 | 17 | 0.030 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2015 | 9 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2015 | 44 | 0.030 |
Why?
|
| Lipid Peroxidation | 1 | 2015 | 140 | 0.030 |
Why?
|
| Estrogen Receptor alpha | 1 | 2015 | 121 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2015 | 258 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 665 | 0.020 |
Why?
|
| Cathepsin L | 2 | 2004 | 15 | 0.020 |
Why?
|
| Entropy | 1 | 2012 | 14 | 0.020 |
Why?
|
| Transfection | 2 | 2003 | 532 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 374 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2012 | 195 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2012 | 299 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2015 | 609 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 1009 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2012 | 1285 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 863 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 2853 | 0.010 |
Why?
|
| Endosomes | 1 | 2004 | 33 | 0.010 |
Why?
|
| Transport Vesicles | 1 | 2004 | 22 | 0.010 |
Why?
|
| Risk Factors | 1 | 2012 | 3994 | 0.010 |
Why?
|
| Carmustine | 1 | 2003 | 1 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2003 | 62 | 0.010 |
Why?
|
| Carboplatin | 1 | 2003 | 20 | 0.010 |
Why?
|
| Protein Transport | 1 | 2004 | 296 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2003 | 195 | 0.010 |
Why?
|
| Receptor, IGF Type 2 | 1 | 2002 | 7 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2003 | 173 | 0.010 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2002 | 4 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2002 | 64 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2002 | 43 | 0.010 |
Why?
|
| Microsomes | 1 | 2002 | 55 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2002 | 95 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 508 | 0.010 |
Why?
|
| ras Proteins | 1 | 2002 | 54 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2002 | 210 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2002 | 127 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 384 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2003 | 273 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2002 | 883 | 0.010 |
Why?
|
| Aged | 1 | 2012 | 8214 | 0.010 |
Why?
|
| Time Factors | 1 | 2002 | 1857 | 0.010 |
Why?
|
| Middle Aged | 1 | 2012 | 12222 | 0.010 |
Why?
|